CClinicalTrials.gg
CompletedNCT02510729Updated Aug 16, 2017

SPG Neurostimulation in Cluster Patients

An interventional study of Neurostimulation and Sham stimulation in Chronic Cluster Headache, sponsored by Danish Headache Center. Completed at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2017-08-16.

Sponsored by Danish Headache Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Sex
All
01

Study summary

We hypothesized that LF stimulation of the SPG would increase parasympathetic outflow, activate sensory afferents and provoke a cluster-like attack.

Read the detailed description

We conducted a double-blind, randomized, sham-controlled, crossover study to investigate cluster attack induction following LF (20 Hz and 0.2-2.1 amplitude) and sham (amplitude = 0) stimulation in 20 CH patients with implanted SPG neurostimulator. In addition, we measured plasma concentrations of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal peptide (VIP), as markers for parasympathetic activation before, during and after SPG stimulation. We also investigated if LF SPG stimulation induces changes in cardiac autonomic regulation and whether any attacks induced by SPG stimulation are associated with such changes.

02

Conditions studied

  • Chronic Cluster Headache
03

In context

Cluster Headache

116 studies on the registry are indexed under Cluster Headache; 27 are open to participants now.

This study's enrollment of 21 is below the median of 42 across 86 interventional studies indexed under Cluster Headache.

Browse Cluster Headache studies →

Lead sponsor

Danish Headache Center is the lead sponsor of 125 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chronic cluster patients

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
21 participants (actual)

Study arms

  • Active comparator
    SPG neurostimulation

    Sphenopalatine ganglion (SPG) neurostimulation of 20 Hz

    Device: Neurostimulation

  • Placebo comparator
    Sham Stimulation

    Sham stimulation with amplitude=0

    Device: Sham stimulation

Interventions

  • DeviceNeurostimulation
  • DeviceSham stimulation
06

What researchers measure

Primary outcomes

  1. Incidence of cluster-like attacks and cephalic autonomic symptoms

    Difference in incidence of cluster-like attacks and cephalic autonomic symptoms between LF and sham stimulation.

    Time frame: 0-60 min

Secondary outcomes

  1. Mechanical detection and pain thresholds

    Difference in mechanical detection and pain thresholds in the face between LF and sham stimulation measured by pin-prick and von Frey hairs.

    Time frame: 0-60 min

  2. Plasma concentrations of PACAP38 and VIP

    Difference in plasma concentrations of PACAP38 and VIP between LF and sham stimulation.

    Time frame: 0-60 min

  3. Cardiac autonomic regulation (HRV)

    Changes in cardiac autonomic regulation (HRV) between LF and sham stimulation and during cluster attacks measured by continious ECG.

    Time frame: 0-60 min

  4. Mean arterial blood pressure and heart rate

    Difference in mean arterial blood pressure and heart rate between LF and sham stimulation.

    Time frame: 0-60 min

  5. Headache intensity

    Difference in headache intensity measured by numerical rating scale (NRS 0-10) between LF and sham stimulation.

    Time frame: 0-60 min

07

Study locations

1 site
  • Danish Headache Center
    Copenhagen, Glostrup 2600, Denmark
08

References and documents

Publications

  • Guo S, Petersen AS, Schytz HW, Barlose M, Caparso A, Fahrenkrug J, Jensen RH, Ashina M. Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks. Cephalalgia. 2018 Jul;38(8):1418-1428. doi: 10.1177/0333102417738250. Epub 2017 Oct 30. PubMed 29082824 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02510729
Lead sponsor
Danish Headache Center
Responsible party
Song Guo (MD, PhD student, Danish Headache Center) — Principal investigator
First posted
Jul 29, 2015
Start date
Jul 2015
Primary completion
May 2016
Completion
Oct 2016
Last update
Aug 16, 2017

Study contacts

Messoud Ashina, Prof.
principal investigator · Danish Headache Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion